Increased cortico-cortical functional connectivity in early-stage Parkinson's disease: An MEG study von Stoffers, D., Bosboom, J.L.W., Deijen, J.B., Wolters, E.Ch, Stam, C.J., Berendse, H.W.

Volltext

Resting state oscillatory brain dynamics in Parkinson’s disease: An MEG study von Bosboom, J.L.W., Stoffers, D., Stam, C.J., van Dijk, B.W., Verbunt, J., Berendse, H.W., Wolters, E.Ch

Volltext

Loss of olfaction in de novo and treated Parkinson's disease: Possible implications for early diagnosis von Tissingh, G., Berendse, H.W., Bergmans, P., DeWaard, R, Drukarch, B., Stoof, J.C., Wolters, E.Ch

Volltext

Cholinergic modulation of MEG resting-state oscillatory activity in Parkinson’s disease related dementia von Bosboom, J.L.W, Stoffers, D, Stam, C.J, Berendse, H.W, Wolters, E.Ch

Volltext

Standardized human bone marrow-derived stem cells infusion improves survival and recovery in a rat model of spinal cord injury von Munter, J.P. de, Beugels, J., Munter, S., Jansen, L., Cillero-Pastor, B., Moskvin, O., Brook, G., Pavlov, D., Strekalova, T., Kramer, B.W., E.Ch, Wolters

Volltext

A.1 Unmet medical needs in the treatment of Parkinson's Disease von Wolters, E.Ch

Volltext

Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease von WOLTERS, E. C, JANSEN, E. N. H, TUYNMAN-QUA, H. G, BERGMANS, P. L. M

Volltext

Introduction von Wolters, E.Ch, Berendse, H.W., Stam, C.J.

Volltext

Effects of unilateral 6-hydroxydopamine lesions on neuropeptide immunoreactivity in the basal ganglia of the common marmoset, Callithrix jacchus, a quantitative immunohistochemical... von Roeling, T.A.P., Docter, G.J., Voorn, P., Melchers, B.P.C., Wolters, E.Ch, Groenewegen, H.J.

Volltext

IV.P12 The influence of dopaminomimetics on resting state functional connectivity in Parkinson's Disease: an MEG study von Stoffers, D., Bosboom, J.L.W., Wolters, E.Ch, Berendse, H.W., Stam, C.J.

Volltext

V.9 Cognitive dysfunction and dementia in Parkinson's Disease: EEG/MEG experience von Bosboom, J.L.W., Stoffers, D., Stam, C.J., Berendse, H.W., Wolters, E.ch

Volltext

I.P15 The predictive value of olfactory dysfunction and cognitive dysfunction for preclinical Parkinson's Disease von Ponsen, M.M., Stoffers, D., Wolters, E.Ch, Berendse, H.W.

Volltext

P-4-69 Olanzapine in the treatment of dopaminomimetic psychosis von Wolters, E.Ch

Volltext

Deficits on Corsi's block-tapping task in early stage Parkinson's disease von Stoffers, D, Berendse, H.W, Deijen, J.B, Wolters, E.Ch

Volltext

IV.P5 Efficacy of a group physical therapy program in patients with Parkinson's Disease: a randomized controlled trial von de Goede, C., Ellis, T., Feldman, R., Wolters, E.Ch, Kwakkel, G., Wagenaar, R.

Volltext

V.10 The neurophysiology of dementia in Parkinson's Disease: does connectivity count? von Stam, C.J., Bosboom, J.L.W., Stoffers, D., van Dijk, B.W., Verbunt, J., Berendse, H.W., Wolters, E.ch

Volltext

Historical overview of the WFN-organised Congresses on Parkinson's Disease and Related Disorders von Battistin, L, Korczyn, A.D, Wolters, E.Ch

Volltext

First case of ataxia with isolated vitamin E deficiency in the Netherlands von Ponten, S.C, Kwee, M.L, Wolters, E.Ch, Zijlmans, J.C.M

Volltext

1.112 Olfactory dysfunction in Parkinson's disease: Is extended testing useful to discriminate between patients and controls? von Boesveldt, S, de Muinck Keizer, R.-J, Wolters, E.Ch, Berendse, H.W

Volltext

3.101 Functional connectivity in Parkinson's disease related dementia: A MEG study von Bosboom, J.L, Stoffers, D, Wolters, E.Ch, Stam, K, Berendse, H.W

Volltext